Expression of Id3 represses exhaustion of anti-tumor CD8 T cells in liver cancer
Yun Jin,Pingping Hu,Haihang Sun,Chao Yang,Jianxin Zhai,Yi Wang,Xinyun Chu,Zhiwei Sun,Jia Wang,Jie Sun,Junfeng Wang
DOI: https://doi.org/10.1016/j.molimm.2022.02.005
IF: 4.174
2022-04-01
Molecular Immunology
Abstract:Id3, an inhibitor of DNA binding protein, plays important roles in the function and homeostasis of effector and memory T cells. Recent evidence has shown that Id3 is also implicated in CD8 T cell exhaustion. However, whether and how Id3 might regulate effector function or exhaustion of CD8 T cells, especially in the tumor setting, is still unknown. Here, we first showed that Id3 expression was impaired in tumor-infiltrating CD8 T cells as liver cancer progressed, especially in PD-1 +Tim-3 + exhausted CD8 T cells. Enforced expression of Id3 in CD8 T cells resulted in repressed development of anti-tumor CTLs exhaustion, which offered better tumor control. And partially depletion of Id3 in CD8 T cells promoted the development of exhausted CD8 T cells. Furthermore, Id3hi CD8 T cells could respond to PD-1 blockade. Collectively, Id3 exerts protective functions in CD8 T cells for liver cancer.
biochemistry & molecular biology,immunology
What problem does this paper attempt to address?